ACIDE ZOLEDRONIQUE ZENTIVA LAB 4 mg/100 ml, solution for infusion bottle, 100 ml
Active ingredients: Anhydrous zoledronic acid, Zoledronic acid monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for infusionbottle, 100 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACIDE ZOLEDRONIQUE ZENTIVA LAB 4 mg/100 ml, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 100 ml ( abrogée le 18/12/2024)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 7 Sept 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65148121CIP72779513CIP133400927795138Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE ZOLÉDRONIQUE ANHYDREsolution | 4 mg · une poche de 100 ml de solution pour perfusion | FT |
| ACIDE ZOLÉDRONIQUE MONOHYDRATÉsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.